搜尋結果

共 2021 個結果
頁數:1...21 22 23 24 25 26 27 28 29 ...102

Measuring poverty properly

... lenges of COVID-19 and climate change. The poor suffer the most in times of crisis because they lack the social capital that protects those who are better off. To paraphrase Martin Luther King, Jr., t ...More

EJ Insight2022-02-17

當科學遇上政治:從一項口罩研究說起

... ssociated COVID-19 Outbreaks - Maricopa and Pima Counti ...全文

今日信報理財投資經濟3.0曾國平2022年02月17日

Europe must be Africa’s partner of choice

After being postponed several times because of the COVID-19 pandemic, this month’s European Union-African Union Summit in Brussels (February 17-18) will bring together European and African heads of st ...More

EJ Insight2022-02-16

倫敦租房有感

... 模式本來就有欠理想,COVID-19爆發後,大部分鐵路公司減少火車班次,縮減開支,亦有因人手短缺未能維持服務班 ...全文

今日信報副刊文化酒食浪遊劉群章2022年02月16日

How investors can update their income strategies

... impact of Covid-19 has extended this cycle. Suppressed (and in many cases negative) investment-grade bond yields have driven investors into riskier asset classes in search of growth and income, most c ...More

EJ Insight2022-02-15

Climate accountability now

... njustice, COVID-19 has exposed and exacerbated the policy failures of the past three decades. Political leaders have not lived up to their previous commitments. To overcome inertia, policymakers every ...More

EJ Insight2022-02-15

Fraud abroad: How SMBs can expand globally and stay secure

... ears. The COVID-19 pandemic greatly accelerated a digital wave of change across almost every industry by three to five years. At the same time, this digital wave also presented an almost ideal scenari ...More

EJ Insight2022-02-14

Crisis management requires good use of innovative technology

... ng of the COVID-19 outbreak two years ago, the government used an interactive map dashboard to release important information of the pandemic in real time to help people grasp the trend of the epidemic ...More

EJ Insight2022-02-14

從足球員確診看疫症影響

... nfection: COVID-19 and Performance at Work 的工作論文(還未在學報正 ...全文

今日信報理財投資經濟3.0梁天卓2022年02月12日

中藥防治「新冠」是草還是寶之三

... e against COVID-19: Clinical experience and scientific ...全文

今日信報副刊文化自講自治黃譚智媛2022年02月11日

推高疫苗接種率的成本效益

... 洲的CoRiCal(COVID-19 Risk Calculator)早前利用國內最新數據(90% Omicr ...全文

今日信報理財投資經濟3.0梁天卓2022年02月11日

Make capitalism competitive again

... uring the COVID-19 pandemic, with governments everywhere adopting a “whatever it takes” attitude and spending almost $17 trillion so far to get through the crisis. The bill for this unavoidable larges ...More

EJ Insight2022-02-10

China’s big picture

... until the COVID-19 pandemic, China was still growing in line with what was implied in the original BRIC thesis. In our analysis, we postulated that China could become as large as the US in nominal ter ...More

EJ Insight2022-02-10

清零或毒存?只看一關鍵…

... 士會在夏季消退,推斷COVID-19也將很快消散──經驗反映,這個說法錯誤透頂。不少專家學者今日亦指,疫苗普及 ...全文

今日信報時事評論李道2022年02月10日

The dilemma Hong Kong confronts

... y and all COVID-19 cases – through targeted treatments, ...全文

今日信報時事評論EJ InsightBrian Wong2022年02月09日

【輪證贏家】恒指熊追小時圖繼續向下

... opic就更係偉大嘅COVID-19啦,今日預咗佢過千宗確診,所以如果要張竹君逐個逐個咁講佢哋有無打針、喺邊度 ...全文

即時新聞即巿股評2022年02月08日

A balanced response to inflation

Although some supply shortages were anticipated as the global economy reopened after the COVID-19 lockdowns, they have proved more pervasive, and less transitory, than had been hoped. In a market econ ...More

EJ Insight2022-02-08

The dilemma Hong Kong confronts

... y and all COVID-19 cases – through targeted treatments, of course. Let us now consider the second option – that is, reopening Hong Kong to the world at large. The benefits are apparent. We’re a financ ...More

EJ Insight2022-02-07

高盛:藥明發盈喜 連升3日重上80元 留意貼價購18980、高槓桿購19984,貼牛50177

... 進執行現存及新引進的COVID-19項目,料截至去年十二月底止年度利潤及歸屬於公司權益股東的利潤,按年分別增長 ...全文

港股360輪證攻略2022年02月07日

【異動股】藥明生物升3% 料全年純利增近倍

... 進執行現存及新引進的COVID-19項目,以及集團新的非新冠綜合項目收益和市場份額顯著增加等。 其他主要的生物 ...全文

即時新聞港股直擊2022年02月07日

頁數:1...21 22 23 24 25 26 27 28 29 ...102

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。